Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux AC, Scemama O, Quantin C, Béjean S, Stillwaggon E, Wallon M.

PLoS One. 2019 Sep 18;14(9):e0221709. doi: 10.1371/journal.pone.0221709. eCollection 2019.

2.

Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group.

Peyron F, L'ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, Hadjadj E, Paris L, Garcia-Meric P.

Pathogens. 2019 Feb 18;8(1). pii: E24. doi: 10.3390/pathogens8010024.

3.

Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision.

Li X, Pomares C, Peyron F, Press CJ, Ramirez R, Geraldine G, Cannavo I, Chapey E, Levigne P, Wallon M, Montoya JG, Dai H.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):883-890. doi: 10.1007/s10096-019-03487-1. Epub 2019 Jan 30.

PMID:
30701339
4.

Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment.

Robert MG, Faisant A, Cognet O, Rabodonirina M, Peyron F, Piquemal M, Mazet R, Pelloux H, Brenier-Pinchart MP.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e163-e164. doi: 10.1111/jdv.15356. Epub 2018 Dec 7. No abstract available.

PMID:
30468533
5.

Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis.

El Bissati K, Levigne P, Lykins J, Adlaoui EB, Barkat A, Berraho A, Laboudi M, El Mansouri B, Ibrahimi A, Rhajaoui M, Quinn F, Murugesan M, Seghrouchni F, Gómez-Marín JE, Peyron F, McLeod R.

Emerg Microbes Infect. 2018 Sep 27;7(1):165. doi: 10.1038/s41426-018-0164-4. Review.

6.

Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies.

Lykins J, Li X, Levigne P, Zhou Y, El Bissati K, Clouser F, Wallon M, Morel F, Leahy K, El Mansouri B, Siddiqui M, Leong N, Michalowski M, Irwin E, Goodall P, Ismail M, Christmas M, Adlaoui EB, Rhajaoui M, Barkat A, Cong H, Begeman IJ, Lai BS, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Peyron F, McLeod R.

PLoS Negl Trop Dis. 2018 Aug 16;12(8):e0006536. doi: 10.1371/journal.pntd.0006536. eCollection 2018 Aug. No abstract available.

7.

Oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate in lung cancer surgery: a randomized clinical trial.

D'Journo XB, Falcoz PE, Alifano M, Le Rochais JP, D'Annoville T, Massard G, Regnard JF, Icard P, Marty-Ane C, Trousse D, Doddoli C, Orsini B, Edouard S, Million M, Lesavre N, Loundou A, Baumstarck K, Peyron F, Honoré S, Dizier S, Charvet A, Leone M, Raoult D, Papazian L, Thomas PA.

Intensive Care Med. 2018 May;44(5):578-587. doi: 10.1007/s00134-018-5156-2. Epub 2018 Apr 18.

PMID:
29671041
8.

Congenital Toxoplasmosis: A Plea for a Neglected Disease.

Wallon M, Peyron F.

Pathogens. 2018 Feb 23;7(1). pii: E25. doi: 10.3390/pathogens7010025.

9.

Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients.

Mathis T, Beccat S, Sève P, Peyron F, Wallon M, Kodjikian L.

Br J Ophthalmol. 2018 Oct;102(10):1454-1458. doi: 10.1136/bjophthalmol-2017-311528. Epub 2018 Jan 17.

PMID:
29343531
10.

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries.

Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Stillwaggon E, Peyron F, McLeod R.

PLoS Negl Trop Dis. 2017 Jun 26;11(6):e0005670. doi: 10.1371/journal.pntd.0005670. eCollection 2017 Jun.

11.

Eight cases of cutaneous leishmaniasis due to Leishmania infantum with protean presentation.

Dupont D, Phan A, Durupt F, Peyron F.

Eur J Dermatol. 2017 Aug 1;27(4):422-423. doi: 10.1684/ejd.2017.3036. No abstract available.

PMID:
28492171
12.

Cutaneous myiasis.

Graveriau C, Peyron F.

Travel Med Infect Dis. 2017 Mar - Apr;16:70-71. doi: 10.1016/j.tmaid.2017.03.008. Epub 2017 Mar 20. No abstract available.

PMID:
28336471
13.

Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?: (Trends in Parasitology 33, 93-101; 2017).

Rougier S, Montoya JG, Peyron F.

Trends Parasitol. 2017 May;33(5):414. doi: 10.1016/j.pt.2017.02.001. Epub 2017 Feb 21. No abstract available.

PMID:
28236522
14.

Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.

Peyron F, Mc Leod R, Ajzenberg D, Contopoulos-Ioannidis D, Kieffer F, Mandelbrot L, Sibley LD, Pelloux H, Villena I, Wallon M, Montoya JG.

PLoS Negl Trop Dis. 2017 Feb 16;11(2):e0005222. doi: 10.1371/journal.pntd.0005222. eCollection 2017 Feb. No abstract available.

15.

In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.

Dupont D, Peyron F.

Pediatr Infect Dis J. 2017 Mar;36(3):350. doi: 10.1097/INF.0000000000001436. No abstract available.

PMID:
28187119
16.

Lifelong Persistence of Toxoplasma Cysts: A Questionable Dogma?

Rougier S, Montoya JG, Peyron F.

Trends Parasitol. 2017 Feb;33(2):93-101. doi: 10.1016/j.pt.2016.10.007. Epub 2016 Dec 8. Review. Erratum in: Trends Parasitol. 2017 May;33(5):414.

PMID:
27939103
17.

Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM.

Chapey E, Wallon M, Peyron F.

Clin Chim Acta. 2017 Jan;464:200-201. doi: 10.1016/j.cca.2016.10.023. Epub 2016 Oct 17.

PMID:
27765564
18.

Assessment of the diagnostic performance of the IDS-iSYS tests for toxo IgG, toxo IgM and avidity.

Levigne P, Peyron F, Wallon M.

Diagn Microbiol Infect Dis. 2016 Oct;86(2):148-52. doi: 10.1016/j.diagmicrobio.2016.07.006. Epub 2016 Jul 9.

PMID:
27450223
19.

Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.

Teil J, Dupont D, Charpiat B, Corvaisier S, Vial T, Leboucher G, Wallon M, Peyron F.

Pediatr Infect Dis J. 2016 Jun;35(6):634-8. doi: 10.1097/INF.0000000000001120.

PMID:
26906163
20.

Place of Interferon-γ Assay for Diagnosis of Congenital Toxoplasmosis.

Chapey E, Wallon M, L'Ollivier C, Piarroux R, Peyron F.

Pediatr Infect Dis J. 2015 Dec;34(12):1407-9. doi: 10.1097/INF.0000000000000901.

PMID:
26780025
21.

Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis.

Wallon M, Peyron F.

Clin Infect Dis. 2016 Mar 15;62(6):811-2. doi: 10.1093/cid/civ1035. Epub 2015 Dec 21. No abstract available.

PMID:
26689954
22.

[Motivations for a consultation before adoption: A multicenter study].

Thieblemont M, Francois P, Poirier V, Bosdure E, Munck MR, Borsa-Dorion A, Hazart I, Moukagni-Pelzer M, Brunel D, Peyron F, de Monleon JV.

Arch Pediatr. 2016 Jan;23(1):39-44. doi: 10.1016/j.arcped.2015.10.003. Epub 2015 Nov 12. French.

PMID:
26586547
23.

Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis.

Chapey E, Meroni V, Kieffer F, Bollani L, Ecochard R, Garcia P, Wallon M, Peyron F.

Clin Vaccine Immunol. 2015 Apr;22(4):398-403. doi: 10.1128/CVI.00552-14. Epub 2015 Feb 4.

24.

Cesarean delivery or induction of labor does not prevent vertical transmission of toxoplasmosis in late pregnancy.

Wallon M, Kieffer F, Huissoud C, Peyron F.

Int J Gynaecol Obstet. 2015 May;129(2):176-7. doi: 10.1016/j.ijgo.2014.10.026. Epub 2014 Dec 22. No abstract available.

PMID:
25556076
25.

Dermatophytes and transmission risks to family: a retrospective study of a cohort of 256 adopted children from 1998 to 2012.

Dupont D, Peyron F, Picot S, Wallon M, Bienvenu AL.

Pediatr Dermatol. 2015 May-Jun;32(3):426-7. doi: 10.1111/pde.12431. Epub 2014 Sep 18.

PMID:
25233935
26.

Surgical management of liver hydatid disease: subadventitial cystectomy versus resection of the protruding dome.

Mohkam K, Belkhir L, Wallon M, Darnis B, Peyron F, Ducerf C, Gigot JF, Mabrut JY.

World J Surg. 2014 Aug;38(8):2113-21. doi: 10.1007/s00268-014-2509-z.

PMID:
24969045
27.

Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.

Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, Bonithon-Kopp C, Picot S, Peyron F, Binquet C.

Pediatrics. 2014 Mar;133(3):e601-8. doi: 10.1542/peds.2013-2153. Epub 2014 Feb 17.

PMID:
24534412
28.

[Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis].

Lenvers P, Marty P, Peyron F.

Ann Dermatol Venereol. 2013 Nov;140(11):704-7. doi: 10.1016/j.annder.2013.07.003. Epub 2013 Aug 7. French.

PMID:
24206806
29.

[Congenital toxoplasmosis: long-term ophthalmologic follow-up praised by patients].

Beraud L, Rabilloud M, Fleury J, Wallon M, Peyron F.

J Fr Ophtalmol. 2013 Jun;36(6):494-8. doi: 10.1016/j.jfo.2012.10.008. Epub 2013 Feb 19. French.

PMID:
23428138
30.

First identification of eggs of the Asian fish tapeworm Bothriocephalus acheilognathi (Cestoda: Bothriocephalidea) in human stool.

Yera H, Kuchta R, Brabec J, Peyron F, Dupouy-Camet J.

Parasitol Int. 2013 Jun;62(3):268-71. doi: 10.1016/j.parint.2013.02.001. Epub 2013 Feb 17.

PMID:
23422154
31.

Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.

Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C.

Clin Infect Dis. 2013 May;56(9):1223-31. doi: 10.1093/cid/cit032. Epub 2013 Jan 29.

PMID:
23362291
32.

Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis.

L'Ollivier C, Wallon M, Faucher B, Piarroux R, Peyron F, Franck J.

Clin Vaccine Immunol. 2012 Aug;19(8):1326-8. doi: 10.1128/CVI.00060-12. Epub 2012 Jun 13.

33.

Seasonal variations in acute toxoplasmosis in pregnant women in the Rhône-Alpes region (France).

Morin L, Lobry JR, Peyron F, Wallon M.

Clin Microbiol Infect. 2012 Oct;18(10):E401-3. doi: 10.1111/j.1469-0691.2012.03898.x. Epub 2012 May 23.

34.

Imported cutaneous leishmaniasis in a short-term traveler returning from Central Mali - The role of PCR.

Kelly P, Baudry T, Peyron F.

Travel Med Infect Dis. 2012 Mar;10(2):97-100. doi: 10.1016/j.tmaid.2012.01.004. Epub 2012 Mar 8.

PMID:
22405679
35.

[Congenital toxoplasmosis: randomised comparison of strategies for retinochoroiditis prevention].

Wallon M, Kieffer F, Binquet C, Thulliez P, Garcia-Méric P, Dureau P, Franck J, Peyron F, Bonnin A, Villena I, Bonithon-Kopp C, Gouyon JB, Masson S, Félin A, Cornu C.

Therapie. 2011 Nov-Dec;66(6):473-80. doi: 10.2515/therapie/2011070. Epub 2011 Dec 21. French.

PMID:
22186072
36.

Congenital parasitic infections: a review.

Carlier Y, Truyens C, Deloron P, Peyron F.

Acta Trop. 2012 Feb;121(2):55-70. doi: 10.1016/j.actatropica.2011.10.018. Epub 2011 Nov 7. Review.

PMID:
22085916
37.

Evaluation of an immunochromatographic assay: Giardia-Strip® (Coris BioConcept) for detection of Giardia intestinalis in human fecal specimens.

Nguyen TK, Kherouf H, Blanc-Pattin V, Allais E, Chevalier Y, Richez A, Ramade C, Peyron F.

Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):623-5. doi: 10.1007/s10096-011-1332-9. Epub 2011 Jul 6. No abstract available.

PMID:
21732200
38.

[Imprecision of vancomycin prepared for intravenous administration at the bedside in a neonatal intensive care unit].

Popescu M, Vialet R, Loundou A, Peyron F, Buès-Charbit M.

Ann Fr Anesth Reanim. 2011 Oct;30(10):726-9. doi: 10.1016/j.annfar.2011.04.013. Epub 2011 Jun 29. French.

PMID:
21719238
39.

Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.

Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J.

Pediatr Infect Dis J. 2011 Jul;30(7):597-600. doi: 10.1097/INF.0b013e31820bb5f3.

PMID:
21278618
40.

Mefloquine adverse effects with atypical facial lesions in an overweight patient.

Descloux E, De Monbrison F, Basselin C, Vial T, Peyron F.

Travel Med Infect Dis. 2010 Sep;8(5):318-21. doi: 10.1016/j.tmaid.2010.06.003. Epub 2010 Aug 6.

PMID:
20971443
41.

Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid.

Wallon M, Franck J, Thulliez P, Huissoud C, Peyron F, Garcia-Meric P, Kieffer F.

Obstet Gynecol. 2010 Apr;115(4):727-33. doi: 10.1097/AOG.0b013e3181d57b09.

PMID:
20308831
42.

In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management.

Rabilloud M, Wallon M, Peyron F.

Pediatr Infect Dis J. 2010 May;29(5):421-5. doi: 10.1097/INF.0b013e3181c80493.

PMID:
19952858
43.

Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay.

Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F.

J Clin Microbiol. 2010 Jan;48(1):41-5. doi: 10.1128/JCM.01903-09. Epub 2009 Nov 18.

44.

[Improvement of quality of practices for the preparation of cytotoxic drugs: results of a "before-after" study].

Gilles L, Favier B, Catillon F, Dussart C, Peyron F, Simoens X, Latour JF, Farsi F, Biron P.

Bull Cancer. 2009 Sep;96(9):839-49. doi: 10.1684/bdc.2009.0922. French.

45.
46.

Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France.

Cornu C, Bissery A, Malbos C, Garwig R, Cocherel C, Ecochard R, Peyron F, Wallon M.

Euro Surveill. 2009 Mar 5;14(9):21-5.

47.

Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America.

Morisset S, Peyron F, Lobry JR, Garweg J, Ferrandiz J, Musset K, Gomez-Marin JE, de la Torre A, Demar M, Carme B, Mercier C, Garin JF, Cesbron-Delauw MF.

Microbes Infect. 2008 Jun;10(7):742-7. doi: 10.1016/j.micinf.2008.04.001. Epub 2008 Apr 9.

PMID:
18539501
48.

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis.

Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, Kirisits MJ, Miller EN, Peacock CS, Hargrave AC, Coyne JJ, Boyer K, Bessieres MH, Buffolano W, Ferret N, Franck J, Kieffer F, Meier P, Nowakowska DE, Paul M, Peyron F, Stray-Pedersen B, Prusa AR, Thulliez P, Wallon M, Petersen E, McLeod R, Gilbert RE, Blackwell JM.

PLoS One. 2008 Jun 4;3(6):e2285. doi: 10.1371/journal.pone.0002285.

49.

Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.

Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J.

Pediatr Infect Dis J. 2008 Jan;27(1):27-32.

PMID:
18162934
50.

Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Lefevre-Pettazzoni M, Bissery A, Wallon M, Cozon G, Peyron F, Rabilloud M.

Clin Vaccine Immunol. 2007 Mar;14(3):239-43. Epub 2007 Jan 3.

Supplemental Content

Loading ...
Support Center